Overview

Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include rate of MRSA acquisition, and of other hospital-acquired infections (e.g., catheter-associated bloodstream infections).

Phase:

N/A

Details

Lead Sponsor:

Christiana Care Health Services

Collaborator:

Sage Products, Inc.

Treatments:

Chlorhexidine
Chlorhexidine gluconate
Methicillin